Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Nasal Drug Delivery in Traditional Persian Medicine

Mohammad Mehdi Zarshenas 1 , 2 , Arman Zargaran 3 , 4 , * , Johannes Müller 5 and Abdolali Mohagheghzadeh 2 , 3
Authors Information
1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Traditional Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Research Office for the History of Persian Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
5 University of Marburg, Institute for the History of Pharmacy, Germany
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 17, 2013, 8 (3); 144-148
  • Published Online: July 16, 2013
  • Article Type: Rapid Communication
  • Received: December 27, 2012
  • Revised: March 13, 2013
  • Accepted: April 15, 2013
  • DOI: 10.17795/jjnpp-9990

To Cite: Zarshenas M M, Zargaran A, Müller J, Mohagheghzadeh A. Nasal Drug Delivery in Traditional Persian Medicine, Jundishapur J Nat Pharm Prod. 2013 ; 8(3):144-148. doi: 10.17795/jjnpp-9990.

Copyright © 2013, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Borchardt JK. The Beginnings of Drug Therapy: Ancient Mesopotamian Medicine. Drug News Perspect. 2002; 15(3): 187-192[DOI][PubMed]
  • 2. Kasthuri KT, Radha R, Jayshree N, Austin A, Thirugnanasambantham P. Standardization and In Vitro Anti Inflammatory Studies of A Poly Herbal Oil Formulation–Megni. Res J Pharm Technol. 2010; 3(3): 792-4
  • 3. Buerki RA, Higby GJ. Encyclopedia of Pharmaceutical Technology. 2006; : 948-74
  • 4. Levy G. Effect of Dosage Form on Drug Absorption a Frequent Variable in Clinical Pharmacology. Arch Int Pharmacodyn Ther. 1964; 152: 59-68[PubMed]
  • 5. Khaleghi Ghadiri M, Gorji A. Natural remedies for impotence in medieval Persia. Int J Impot Res. 2004; 16(1): 80-3[DOI][PubMed]
  • 6. Zargaran A, Zarshenas MM, Hosseinkhani A, Mehdizadeh A. Jawarish, a Persian traditional gastrointestinal dosage form. Pharm Hist (Lond). 2012; 42(2): 24-5[PubMed]
  • 7. Zargaran A, Zarshenas MM, Mehdizadeh A, Mohagheghzadeh A. Oxymel in medieval Persia. Pharm Hist (Lond). 2012; 42(1): 11-3[PubMed]
  • 8. Ramezany F, Ardakani MR. Ali ibn Hosein Ansari (1330-1404): a Persian pharmacist and his pharmacopoeia, Ekhtiyarat i Badi i. J Med Biogr. 2011; 19(2): 80-3[DOI][PubMed]
  • 9. Levy M. Medical Formulary or Aqrabadhin of Al-Kindi. 1999;
  • 10. Dhuria SV, Hanson LR, Frey WH, 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010; 99(4): 1654-73[DOI][PubMed]
  • 11. Alsarra IA, Hamed AY, Alanazi FK, El Maghraby GM. Drug Delivery to the Central Nervous System. 2010; : 175-203[DOI]
  • 12. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001; 53(1): 3-21[DOI][PubMed]
  • 13. Putheti RR, Patil MC, Obire O. Nasal Drug delivery in Pharmaceutical and biotechnology: present and future. Sci Technol. 2009; 4(3): 1-12
  • 14. Heravi MG. [Qarabadin-e-salehi]. 1765;
  • 15. Avicenna .. [Canon of Medicine]. 1988;
  • 16. Arzani A. [Qarabadin Ghaderi]. 1861;
  • 17. Shirazi SA. [Qarabadin-e-Kabir]. 1855;
  • 18. Azam Khan Cheshti H. [Qarabadin-Azam]. 1809;
  • 19. Shirazi M. [Makhzan ol Advieh]. 1992;
  • 20. [Program Book of Ph.D Degree in Traditional Persian Pharmacy]. 2007;
  • 21. Soltani A. [Dictionary of Medicinal Plants]. 2004;
  • 22. Amin G. [Popular Medicinal Plants of Iran]. 2005;
  • 23. Dymook W, Warden CJH, Hooper D. Pharmacographica Indica. 1893;
  • 24. Baraniuk JN, Merck SJ. Neuroregulation of human nasal mucosa. Ann N Y Acad Sci. 2009; 1170: 604-9[DOI][PubMed]
  • 25. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000; 50(455): 493-6[PubMed]
  • 26. De Ascentiis A, Bettini R, Caponetti G, Catellani PL, Peracchia MT, Santi P, et al. Delivery of nasal powders of beta-cyclodextrin by insufflation. Pharm Res. 1996; 13(5): 734-8[DOI][PubMed]
  • 27. Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett. 2011; 201(3): 191-5[DOI][PubMed]
  • 28. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007; 9(1): 67-9[DOI][PubMed]
  • 29. Amruthesh S. Dentistry and Ayurveda - IV: classification and management of common oral diseases. Indian J Dent Res. 2008; 19(1): 52-61[DOI][PubMed]
  • 30. Bhatted S, Shukla VD, Thakar A, Bhatt NN. A study on Vasantika Vamana (therapeutic emesis in spring season) - A preventive measure for diseases of Kapha origin. Ayu. 2011; 32(2): 181-6[DOI][PubMed]
  • 31. Jadhav KR, Gambhire MN, Shaikh IM, Kadam VJ, Pisal SS. Nasal drug delivery system-factors affecting and applications. Current drug therapy. 2007; 2(1): 27-38
  • 32. Illum L. Nasal drug delivery - recent developments and future prospects. J Control Release. 2012; 161(2): 254-63[DOI][PubMed]
  • 33. Landis MS, Boyden T, Pegg S. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective. Ther Deliv. 2012; 3(2): 195-208[DOI][PubMed]
  • 34. Illum L. Nasal drug delivery--possibilities, problems and solutions. J Control Release. 2003; 87(1-3): 187-98[DOI][PubMed]
  • 35. Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today. 2002; 7(18): 967-75[DOI][PubMed]
  • 36. Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci. 2006; 27(1): 62-71[DOI][PubMed]
  • 37. Schipper NG, Verhoef JC, Merkus FW. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm Res. 1991; 8(7): 807-14[DOI][PubMed]
  • 38. Bhat RB, Jacobs TV. Traditional herbal medicine in Transkei. J Ethnopharmacol. 1995; 48(1): 7-12[DOI][PubMed]
  • 39. Chui SH, Shek SL, Fong MY, Szeto YT, Chan K. A panel study to evaluate quality of life assessments in patients suffering from allergic rhinitis after treatment with a Chinese herbal nasal drop. Phytother Res. 2010; 24(4): 609-13[DOI][PubMed]
  • 40. Chan AS, Cheung MC, Sze SL, Leung WW, Shi D. An herbal nasal drop enhanced frontal and anterior cingulate cortex activity. Evid Based Complement Alternat Med. 2011; 2011: 543648[DOI][PubMed]
  • 41. Bhise SB, Yadav AV, Avachat AM, Malayandi R. Bioavailability of intranasal drug delivery system. Asian J Pharm. 2008; 2(4): 201[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments